Omnicell (OMCL) Capital Expenditures (2010 - 2026)

Omnicell (OMCL) has reported Capital Expenditures for 17 consecutive years, with $8.9 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Capital Expenditures fell 24.12% year-over-year to $8.9 million in Q2 2026; TTM through Jun 2026 was $38.8 million, a 5.06% decrease from a year earlier, with the FY2025 full-year figure at $40.4 million, up 10.84% from the prior year.
• Capital Expenditures was $8.9 million for Q2 2026 at Omnicell, down from $12.4 million in the prior quarter.
• Over five years, Capital Expenditures peaked at $13.7 million in Q4 2022 and troughed at $7.7 million in Q4 2025.
• A 5-year average of $10.4 million and a median of $9.9 million in 2023 frame the typical range for Capital Expenditures.
• Across the five-year window, Capital Expenditures jumped 125.76% in 2022 and plunged 33.67% in 2023, its largest moves.
• Over 5 years, Capital Expenditures stood at $13.7 million in 2022, then sank by 33.67% to $9.1 million in 2023, then grew by 0.19% to $9.1 million in 2024, then dropped by 15.16% to $7.7 million in 2025, then increased by 15.97% to $8.9 million in 2026.
• The last three Capital Expenditures figures came in at $8.9 million (Q2 2026), $12.4 million (Q1 2026), and $7.7 million (Q4 2025), per Business Quant data.